Over 20 million women worldwide suffer from overactive bladder, a condition characterized by sudden and frequent urges to urinate. Kathy Hazzard, an entertainer and real estate agent in her 60s, began ...

The Food and Drug Administration has approved a new patch developed by Watson Pharmaceuticals Inc., for the treatment of an overactive bladder. The patch called Oxytrol (generic: oxybutynin ...

If you suffer from overactive bladder you now have two new options: Botox injections (yes, the wrinkle-shrinking drug), and an over-the-counter version of the Oxytrol patch, which used to require a ...

OXYTROL FOR WOMEN (oxybutynin) 3.9mg transdermal patch by Merck Merck announced that the FDA has approved Oxytrol for Women (oxybutynin transdermal system), the first over-the-counter (OTC) treatment ...

Corona, Calif. – February 26, 2003 – Watson Pharmaceuticals, Inc. (NYSE: WPI), announced today that the U.S. Food and Drug Administration (FDA) has approved OXYTROL tm (oxybutynin transdermal system), ...

WHITEHOUSE STATION, N.J. (AP) -- Merck & Co. said Friday it received approval to market the overactive bladder patch Oxytrol over the counter. Oxytrol has been on the market since 2003 as a treatment ...

The FDA approval of Oxytrol for Women marks the first approval of an over-the-counter (:OTC) treatment for overactive bladder in women. Oxytrol for Women has a proven safety profile with oxybutynin, ...

It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. It delivers the active ingredient, oxybutynin, through your skin and into your bloodstream.

Oxybutynin 3.9mg/day; transdermal patch. ≥18yrs: Apply to clean, dry and smooth area on the abdomen, hips, or buttocks. Use 1 patch for 4 days in a row. Remove patch after 4 days and apply new one.

Merck, the third-largest U.S. drugmaker by revenue, may not have shown that women can safely use the company’s overactive-bladder medication Oxytrol without a doctor prescription, U.S. regulators said ...

Merck wants to sell the bladder drug Oxytrol over the counter. Naturally, it has asked FDA for permission to do so. And now, the agency is preparing for an advisory panel meeting to weigh that request ...